BiotechTube

SAGE-217 + Placebo

Phase 3Completed
0 views this week 0 watching💤 Quiet
Interest: 37/100
37
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Depression, Postpartum

Conditions

Depression, Postpartum

Trial Timeline

Jun 8, 2020 → Apr 12, 2022

NCT ID
NCT04442503

About SAGE-217 + Placebo

SAGE-217 + Placebo is a phase 3 stage product being developed by Biogen for Depression, Postpartum. The current trial status is completed. This product is registered under clinical trial identifier NCT04442503. Target conditions include Depression, Postpartum.

What happened to similar drugs?

20 of 20 similar drugs in Depression, Postpartum were approved

Approved (20) Terminated (2) Active (0)
✅DuloxetineEli LillyApproved
✅duloxetineEli LillyApproved
✅DuloxetineEli LillyApproved
✅DuloxetineEli LillyApproved
✅Venlafaxine (Effexor), Duloxetine (Cymbalta), Escitalopram (Lexapro)Eli LillyApproved
✅DuloxetineEli LillyApproved
✅duloxetine + fluoxetine + citalopram + paroxetine + sertralineEli LillyApproved

Hype Score Breakdown

Clinical
17
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (7)

NCT IDPhaseStatus
NCT04442503Phase 3Completed
NCT04442490Phase 3Completed
NCT04007367Phase 3Terminated
NCT03771664Phase 3Terminated
NCT03672175Phase 3Completed
NCT03692910Phase 2Completed
NCT03000530Phase 2Completed

Competing Products

20 competing products in Depression, Postpartum

See all competitors
ProductCompanyStageHype Score
Olanzapine and Fluoxetine combination (OFC) + FluoxetineEli LillyPhase 3
40
DuloxetineEli LillyApproved
35
FK949EAstellas PharmaPhase 3
40
QuetiapineAstellas PharmaPre-clinical
26
duloxetine + escitalopram + placeboEli LillyPhase 3
40
duloxetineEli LillyApproved
43
Duloxetine HydrochlorideEli LillyPhase 3
40
DuloxetineEli LillyApproved
43
DuloxetineEli LillyApproved
43
Venlafaxine (Effexor), Duloxetine (Cymbalta), Escitalopram (Lexapro)Eli LillyApproved
43
Duloxetine + PlaceboEli LillyPhase 3
40
DuloxetineEli LillyApproved
43
duloxetine + fluoxetine + citalopram + paroxetine + sertralineEli LillyApproved
43
Olanzapine + PlaceboEli LillyPhase 3
40
Olanzapine + Fluoxetine + PlaceboEli LillyPhase 3
32
duloxetine + duloxetineEli LillyPre-clinical
26
olanzapine + ziprasidoneEli LillyApproved
43
Olanzapine Fluoxetine Combination (OFC) + PlaceboEli LillyApproved
43
Drug treatment with CymbaltaEli LillyApproved
39
DuloxetineEli LillyApproved
43